Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Auditor change
Director departure
Appointed director
CC transcript

Eterna Therapeutics Inc. (NTN) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/26/2023 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/01/2022 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "RE: Separation Agreement and General Release"
10/01/2021 8-K/A Financial Statements and Exhibits  Interactive Data
04/30/2021 8-K/A Financial Statements and Exhibits
Docs: "Consent of Marcum LLP",
"Audited financial statements of Brooklyn ImmunoTherapeutics LLC as of, and for the fiscal years ended, December 31, 2020 and 2019",
"FINANCIAL STATEMENTS",
"Unaudited pro forma condensed combined financial statements of Brooklyn ImmunoTherapeutics, Inc. for the year ended December 31, 2020, including notes thereto"
03/14/2016 8-K/A Form 8-K/A - Current report [Amend]
06/13/2013 8-K/A Submission of Matters to a Vote of Security Holders
06/15/2006 8-K/A Form 8-K/A - Current report [Amend]
10/14/2003 8-K/A Form 8-K/A - Current report [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy